CombiMatrix files $200 million shelf

By Devika Patel

Knoxville, Tenn., Sept. 11 - CombiMatrix Corp. filed a $200 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers up to $100 million in common stock and up to $100 million in common stock, preferred stock, warrants and debt securities.

The securities may be convertible.

Proceeds will be used for general corporate and working capital purposes, to advance product development and regulatory approvals, to support the company's manufacturing, marketing and sales efforts, to develop new products and technologies and to repay a portion or all of the principal and accrued interest of the secured convertible debenture issued to YA Global Investments, LP. A portion of the proceeds also may be used to acquire or invest in a business or technology.

Based in Mukilteo, Wash., CombiMatrix is a biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.